DUID Panel

Analytes Tested

Δ8-THC
Δ9-THC
11-Hydroxy-Δ9-THC
11-Nor-9-Carboxy-Δ8-THC
11-Nor-9-Carboxy-Δ9-THC
6-Acetylmorphine
7-Aminoclonazepam
8-Aminoclonazolam
Acetone
Acetyl fentanyl
alpha-Hydroxyalprazolam
Alprazolam
Amphetamine
Benzoylecgonine
Buprenorphine
Butalbital
Carisoprodol
Chlordiazepoxide
Clobazam
Clonazepam
Clonazolam
Cocaethylene
Cocaine
Codeine
Cyclobenzaprine
Desalkylflurazepam
Diazepam
Dihydrocodeine/Hydrocodol
EDDP
Estazolam
Ethanol
Etizolam
Fentanyl
Flurazepam
Gabapentin
Hydrocodone
Hydromorphone
Hydroxyethylflurazepam
Hydroxytriazolam
Isopropanol
Ketamine
Loperamide
Lorazepam
LSD
MDA
MDEA
MDMA
Methadone
Methamphetamine
Methanol
Midazolam
Mitragynine
Morphine
Naloxone
Norbuprenorphine
Norcyclobenzaprine
Nordiazepam
Norfentanyl
Norketamine
Norpseudoephedrine
o-Desmethyltramadol
Oxazepam
Oxycodone
Oxymorphone
PCP
Pentobarbital
p-Fluoro fentanyl
Phenobarbital
Phentermine
Pseudoephedrine
Secobarbital
Temazepam
Tramadol
Triazolam
Zolpidem

Methodology

Screening:

Ultra-High-Pressure Liquid Chromatography (UHPLC) coupled to Triple Quadrupole tandem Mass Spectrometry (QqQ MS/MS) and 2-column Headspace Gas Chromatography coupled to flame ionization diction (HS-GC-FID).

Confirmation:

UHPLC-MS/MS confirmatory, quantitative methods and 2-column Headspace Gas Chromatography coupled to flame ionization diction (HS-GC-FID).

Assay Availability

Screening for this assay is setup Mon., Wed., and Fri. while quantitative confirmations are run Mon-Fri.

Results Reported

Typically, ≤ 4 business days from receipt for negative reports. For positive, quantitative reports ≤ 8 business days TAT from receipt.

Acceptable Matrices

Whole Blood; 2 x 4 mL Sodium Fluoride (grey top; preferred) or EDTA (purple top) tubes. Any non-retrievable specimen will be considered.

Storage

Stored at 4oC until testing is completed. Long term storage of samples (1 year) is stored at -20oC.

Causes for Rejection

Identifiers on the specimen DO NOT match, when compared with the requisition.
Specimen handling has compromised the integrity of the specimen (e.g., not stored, or prepared according to testing requirements; frozen specimens and specimens fixed/processed in alternative fixatives)
Specimen quality is compromised at or beyond ability to complete testing and provide accurate results (i.e., quality not sufficient [QNS]).
Serum-separated specimens.